Showing results (1271-1280 of 5,856) with videos related to
Sort By:
Pageof 586
Neurocritical Care|April 24, 2019
Neuroinflammation and Microvascular Dysfunction After Experimental Subarachnoid Hemorrhage: Emerging Components of Early Brain Injury Related to OutcomeJoseph R Geraghty, Joseph L Davis, Fernando D TestaiJournal of Veterinary Emergency and Critical Care (San Antonio, Tex. : 2001)|June 14, 2018
Treatment of carprofen overdose with therapeutic plasma exchange in a dogAstrid B Kjaergaard, Jennifer L Davis, Mark J AciernoBiological Psychiatry|November 24, 1999
The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's diseaseJ I Friedman, D N Adler, K L DavisClinical Biochemistry|February 7, 2001
Biochemical characterization of the minor immunophilinsD L Davis, J N Murthy, S J SoldinPsychopharmacology Communications|January 1, 1976
Tardive dyskinesia and depressive illnessK L Davis, P A Berger, L E HollisterThe American Journal of Medicine|April 12, 2000
Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis CJ B Wong, G L Davis, S G PaukerVeterinary Parasitology|March 7, 2001
Comparative efficacy of several insecticides for control of cattle lice (Mallophaga: Trichodectidae and Anoplura: Haematopinidae)J B Campbell, D J Boxler, R L DavisCurrent Eye Research|July 1, 1990
Hormonal stimulation of 12(R)-HETE, a cytochrome P450 arachidonic acid metabolite in the rabbit corneaK L Davis, M W Dunn, M L SchwartzmanDiagnostic Microbiology and Infectious Disease|March 1, 1990
Prospective randomized study comparing the efficacy and safety of ciprofloxacin with cefaclor in the treatment of patients with purulent bronchitisR W Quenzer, R L Davis, M M NeidhartManaged Care (Langhorne, Pa.)|September 6, 2011
Outcomes and costs associated with initial maintenance therapy with fluticasone propionate-salmeterol xinafoate 250 microg/50 microg combination versus tiotropium in commercially insured patients with COPDAnand A Dalal, Sean D Candrilli, Keith L DavisPageof 586